Metraipolis › archive › dc_fbb39f74294d
Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection Fraction — Europe PMC PMID:41590844
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41590844
- DOI
- 10.3390/jcdd13010017
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T08:26:43.184Z
- SHA-256 of the archived text
8fd2efdf562ba2ec12b32f0b5c0104634577e344b93a3edc6bbbf422432f2ed6- Stable URL of this page
https://metraipolis.com/documento/dc_fbb39f74294d
How to cite
Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection Fraction — Europe PMC PMID:41590844 — Europe PMC (en), https://europepmc.org/article/MED/41590844 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fbb39f74294d (Metraipolis archive dc_fbb39f74294d, sha256 8fd2efdf562ba2ec12b32f0b5c0104634577e344b93a3edc6bbbf422432f2ed6)
BibTeX
@misc{dcfbb39f74294d,
title = {Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection Fraction — Europe PMC PMID:41590844},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41590844},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fbb39f74294d; sha256 8fd2efdf562ba2ec12b32f0b5c0104634577e344b93a3edc6bbbf422432f2ed6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41590844. Agents can read the archived copy with the MCP tool read_document.